CA
ABBV icon

Cannon Advisors’s AbbVie ABBV Stock Holding History

Cannon Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$329K Hold
1,343
– – 0.2% 72
2026
Q1 		$292K Hold
1,343
– – 0.22% 67
2025
Q4 		$298K Sell
1,343
-50
-4% -$11.4K 0.21% 66
2025
Q3 		$318K Buy
1,393
+88
+7% +$17.9K 0.21% 64
2025
Q2 		$242K Buy
1,305
+19
+1% +$3.53K 0.2% 63
2025
Q1 		$269K Hold
1,286
– – 0.25% 53
2024
Q4 		$229K Sell
1,286
-20
-2% -$3.68K 0.19% 56
2024
Q3 		$254K Buy
+1,306
New +$244K 0.21% 58

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Cannon Advisors's ABBV Position: Q2 2026 in Review

Cannon Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 1,343 shares worth $329K. The position accounts for 0.2% of the portfolio, ranked #72.

Cannon Advisors first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cannon Advisors held 1,343 shares of AbbVie worth $329K as of Q2 2026.
  • Cannon Advisors left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.2% of Cannon Advisors's portfolio in Q2 2026, its #72 holding.
  • Cannon Advisors first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cannon Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.